Glycopyrrolate
- Product NDC
- 70860-781
- 11-digit product format
- 708600781
- Labeler code
- 70860
- Product ID
- 70860-781_5a904fde-11d4-4df3-96a2-335d14f78372
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- glycopyrrolate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA210083
- Marketing category
- ANDA
- Marketing start
- 2020-11-30
- Marketing end
- 0000-00-00
- Substance
- GLYCOPYRROLATE
- Active strength
- 0 mg/mL
- Pharmacologic classes
- Anticholinergic [EPC],Cholinergic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70860-781 | GLYCOPYRROLATE INJECTION, SOLUTION [ATHENEX PHARMACEUTICAL DIVISION, LLC.] | 5 | Legacy NDC | 20250130_c444d63b-f394-4ae5-a74d-50105a406574.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-781-01 | 70860078101 | 25 VIAL in 1 CARTON (70860-781-01) > 1 mL in 1 VIAL (70860-781-41) | 25 vial | 2020-11-30 | 0000-00-00 | No | No | Current |
| 70860-781-02 | 70860078102 | 25 VIAL in 1 CARTON (70860-781-02) > 2 mL in 1 VIAL (70860-781-42) | 25 vial | 2020-11-30 | 0000-00-00 | No | No | Current |
| 70860-781-05 | 70860078105 | 25 VIAL in 1 CARTON (70860-781-05) > 5 mL in 1 VIAL (70860-781-43) | 25 vial | 2020-11-30 | 0000-00-00 | No | No | Current |
| 70860-781-20 | 70860078120 | 10 VIAL in 1 CARTON (70860-781-20) > 20 mL in 1 VIAL (70860-781-44) | 10 vial | 2020-11-30 | 0000-00-00 | No | No | Current |